Guided Therapeutics (GTHP) Free Cash Flow (2011 - 2025)
Guided Therapeutics recorded quarterly Free Cash Flow of -$291000.0 in Q4 2025, down 5.05% quarter-over-quarter from -$277000.0 in Q3 2025, and up 12.35% year-over-year from -$259013.4 in Q4 2024.
Guided Therapeutics' Free Cash Flow history runs 15 years deep, the most recent figure standing at -$291000.0 for Q4 2025.
- In Q4 2025, Free Cash Flow rose 12.35% year-over-year to -$291000.0; the TTM figure through Dec 2025 stood at -$1.1 million (up 4.56% YoY), while the FY2025 annual figure was -$1.1 million, up 4.38% from the prior year.
- Free Cash Flow came in at -$291000.0 for Q4 2025 at Guided Therapeutics, down from -$277000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $155000.0 in Q4 2021 to a low of -$744000.0 in Q3 2021.
- A 5-year average of -$352450.0 and a median of -$334000.0 in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow surged 146.83% in 2021 and sank 320.65% in 2022, its largest moves.
- Guided Therapeutics' Free Cash Flow stood at $155000.0 in 2021, then tumbled by 320.65% to -$342000.0 in 2022, then gained by 1.75% to -$336000.0 in 2023, then grew by 1.19% to -$332000.0 in 2024, then increased by 12.35% to -$291000.0 in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$291000.0, -$277000.0, and -$169000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Sep 30, 2025 | -277,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Mar 31, 2025 | -331,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Sep 30, 2024 | -473,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -336,000.00 |
| Dec 31, 2023 | -336,000.00 |
| Sep 30, 2023 | -473,000.00 |
| Sep 30, 2023 | -473,000.00 |
| Jun 30, 2023 | -438,000.00 |
| Jun 30, 2023 | -438,000.00 |
| Mar 31, 2023 | -499,000.00 |
| Mar 31, 2023 | -499,000.00 |
| Dec 31, 2022 | -342,000.00 |
| Dec 31, 2022 | -342,000.00 |
| Sep 30, 2022 | -609,000.00 |
| Sep 30, 2022 | -609,000.00 |
| Jun 30, 2022 | -366,000.00 |
| Jun 30, 2022 | -366,000.00 |
| Mar 31, 2022 | -193,000.00 |
| Mar 31, 2022 | -193,000.00 |
| Dec 31, 2021 | 155,000.00 |
| Dec 31, 2021 | 155,000.00 |
| Sep 30, 2021 | -744,000.00 |
| Sep 30, 2021 | -744,000.00 |
| Jun 30, 2021 | -696,000.00 |
| Jun 30, 2021 | -696,000.00 |
| Mar 31, 2021 | -321,000.00 |
| Mar 31, 2021 | -321,000.00 |
| Dec 31, 2020 | -331,000.00 |
| Dec 31, 2020 | -331,000.00 |
| Sep 30, 2020 | -606,000.00 |
| Sep 30, 2020 | -606,000.00 |
| Jun 30, 2020 | -409,000.00 |
| Jun 30, 2020 | -409,000.00 |
| Mar 31, 2020 | -530,000.00 |
| Mar 31, 2020 | -530,000.00 |
| Dec 31, 2019 | -204,000.00 |
| Dec 31, 2019 | -204,000.00 |
| Sep 30, 2019 | -228,000.00 |
| Sep 30, 2019 | -228,000.00 |
| Jun 30, 2019 | -188,000.00 |
| Jun 30, 2019 | -188,000.00 |
| Mar 31, 2019 | -186,000.00 |
| Mar 31, 2019 | -186,000.00 |
| Dec 31, 2018 | -311,000.00 |
| Dec 31, 2018 | -311,000.00 |
| Sep 30, 2018 | -417,000.00 |
| Sep 30, 2018 | -417,000.00 |
| Jun 30, 2018 | -242,000.00 |
| Jun 30, 2018 | -242,000.00 |
| Mar 31, 2018 | -395,000.00 |
| Mar 31, 2018 | -395,000.00 |
| Dec 31, 2017 | -663,000.00 |
| Dec 31, 2017 | -663,000.00 |
| Sep 30, 2017 | -204,000.00 |
| Sep 30, 2017 | -204,000.00 |
| Jun 30, 2017 | 130,000.00 |
| Jun 30, 2017 | 130,000.00 |
| Mar 31, 2017 | -407,000.00 |
| Mar 31, 2017 | -407,000.00 |
| Dec 31, 2016 | -197,000.00 |
| Dec 31, 2016 | -197,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Dec 31, 2015 | -6,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2015 | -2,000.00 |
| Sep 30, 2014 | -25,000.00 |
| Sep 30, 2014 | -25,000.00 |
| Jun 30, 2014 | -115,000.00 |
| Jun 30, 2014 | -115,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Dec 31, 2013 | 218,000.00 |
| Dec 31, 2013 | 218,000.00 |
| Sep 30, 2013 | -10,000.00 |
| Sep 30, 2013 | -10,000.00 |
| Mar 31, 2013 | -101,000.00 |
| Mar 31, 2013 | -101,000.00 |
| Dec 31, 2012 | 1.05 Mn |
| Dec 31, 2012 | 1.05 Mn |
| Sep 30, 2012 | -145,000.00 |
| Sep 30, 2012 | -145,000.00 |
| Jun 30, 2012 | -481,000.00 |
| Jun 30, 2012 | -481,000.00 |
| Mar 31, 2012 | 130,000.00 |
| Mar 31, 2012 | 130,000.00 |
| Dec 31, 2011 | 180,000.00 |
| Dec 31, 2011 | 180,000.00 |
| Sep 30, 2011 | 229,000.00 |
| Sep 30, 2011 | 229,000.00 |
| Jun 30, 2011 | 19,000.00 |
| Jun 30, 2011 | 19,000.00 |
| Mar 31, 2011 | 16,000.00 |
| Mar 31, 2011 | 16,000.00 |